Seeks to amend notification No. 49/2008- CE (N.T.), dated the 24th December, 2008, so as to prescribe MRP based assessment with 35% abatement thereon, for branded medicaments used in Ayurvedic, Unani, Sidha, Homeopathic or Bio-Chemic systems and to align the tariff lines relating to Pressure Cooker with HS 2012.
MRP based valuation has been prescribed with 35% abatement for non-allopathic medicaments.
Notification No. 1/2013-Central Excise (N.T.)
New Delhi, the 1st March, 2013
G.S.R. (E).-In exercise of the powers conferred by sub-section (1) and sub-section (2) of section 4A of the Central Excise Act, 1944 (1 of 1944), the Central Government hereby makes the following further amendments in the notification of the Government of India in the Ministry of Finance (Department of Revenue), No. 49/2008-Central Excise (N.T.), dated the 24th December, 2008, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide G.S.R. 882(E), dated the 24th December, 2008, namely :-
In the said notification, in the TABLE,-
(i) against serial number 62, for the entry in column (2), the entry “7323 or 7615 10 11” shall be substituted;
(ii) for serial number 125 and the entries relating thereto, the following shall be substituted, namely:-
|‘125||30|| The following goods, namely:-
(i) Medicaments exclusively used in Ayurvedic, Unani, Siddha, Homeopathic or Bio-chemic systems, manufactured in accordance with the formulae described in the authoritative books specified in the First Schedule to the Drugs and Cosmetics Act, 1940 (23 of 1940) or Homeopathic Pharmacopoeia of India or the United States of America or the United Kingdom or the German Homeopathic Pharmacopoeia, as the case may be, and sold under the name as specified in such books or pharmacopoeia;
(ii) Medicaments exclusively used in Ayurvedic, Unani, Siddha, Homeopathic or Bio-chemic systems and sold under a brand name
Explanation.– For the purposes of this entry, “brand name” means a brand name, whether registered or not, that is to say, a name or a mark, such as a symbol, monogram, label, signature or invented words or any writing which is used in relation to a medicament, for the purpose of indicating, or so as to indicate, a connection in the course of trade between the medicament and some person using such name or mark with or without any indication of the identity of that person.
[F No.334/3/2013 -TRU]
Under Secretary to the Government of India
Note.- The principal notification No. 49/2008-Central Excise, dated the 24th December, 2008, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R. 882(E), dated the 24th December, 2008, was last amended vide notification No. 26/2012-Central Excise (N.T.), dated the 10th May,2012, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R. 351(E), dated the 10th May,2012.